Skip to main content
. Author manuscript; available in PMC: 2015 Sep 28.
Published in final edited form as: Cancer Lett. 2013 Aug 21;352(1):28–35. doi: 10.1016/j.canlet.2013.08.026

Figure 4.

Figure 4

EpCAM and sialyl Lewisx (sLe(x)) expression of BT20 cells did not change following treatment with docetaxel or doxorubicin, as evaluated by flow cytometry. Data is presented in histograms wherein the black shaded region represents isotype control, the blue line is the control untreated sample, the red line is the 20% PPC, the orange line is 100% PPC, and the green line is 300% PPC. (A) EpCAM expression on cells treated with docetaxel (A) and doxorubicin (B) sLe(x) expression on cells treated with docetaxel (C) and doxorubicin (D). Figures are representative of three independent experiments.